J&J Subsidiary Licenses PhaseBio Technology

Posted: Jan 3, 2008

Durham, N.C. — Centocor Research and Development is the latest firm to license drug development technology from Phase Bioscience.

Centocor is a subsidiary of Johnson & Johnson.

Financial terms of the licensing deal were not disclosed.

PhaseBio has developed patented technology known as deltaPhase that is used in the production and purification of therapeutics. According to the company, the process delivers increased yields, higher throughput as well as some steps in final product purification.

Centocor has developed treatments for Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis.

Take WRAL.com to go

News Alerts to your Email & Cell Phone

Latest News
- 2009 unlikely to be a ‘breakout year,’ so conserve, says Atlanta VC
  Posted at 6:35 a.m.
- Scale Finance advises Charlotte-based Quaero on $24M sale
  Posted at 6:17 a.m.
- AMD launches Yukon platform for ultraportable computers
  Posted Jan. 6 2:09 p.m.
- Protecting your assets in tough economic times
  Updated Jan. 6 2:01 p.m.
- Start a company in 2009 – Are you nuts? Well, no.
  Posted Jan. 6 1:51 p.m.
more |

Venture/Innovation
- Cisco joins backers for alternative to Microsoft Outlook
  Posted Jan. 6 9:50 a.m.
- Global slowdown could trigger a ‘freeze’ in venture financing, Intersouth partner fears
  Updated Jan. 6 11:34 a.m.
- Atlanta-based Indie Music rolls out popularity tool for musicians
  Jan. 6, 2009
- How to survive nuclear winter? Seize the opportunity for success, says veteran S.C. exec
  Jan. 5, 2009
- VentureSource: Worst venture liquidity in five years
  Jan. 3, 2009
more

Related Items

On The Web

Related Topics

Site Search

J&J Subsidiary Licenses PhaseBio Technology